Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07392892 SSGJ-707 Adenocarcinoma of Esophagus Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07392892 clinical trial report covering SSGJ-707, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07404397 Cyclobenzaprine hydrochloride Pelvic Floor Disorders Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07404397 clinical trial report covering Cyclobenzaprine hydrochloride, Phase 2/3, endpoints, sponsor, geography, readout timing and development white sp
Latest Hotspot
8 min read
NCT07410806 Monepantel Amyotrophic Lateral Sclerosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07410806 clinical trial report covering Monepantel, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07404553 SHR-1918 Hypercholesterolemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07404553 clinical trial report covering SHR-1918, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07412470 Methylprednisolone Renal transplant rejection Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07412470 clinical trial report covering Methylprednisolone, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07413939 Trastuzumab Neoplasm Metastasis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07413939 clinical trial report covering Trastuzumab, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07428369 Lenalidomide Multiple Myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07428369 clinical trial report covering Lenalidomide, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
IRCT20090808002306N11 Vepoloxamer Constipation Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
IRCT20090808002306N11 clinical trial report covering Vepoloxamer, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07424846 Sorbitol Developmental delay Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07424846 clinical trial report covering Sorbitol, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07422311 Dronabinol Alzheimer Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07422311 clinical trial report covering Dronabinol, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07425808 Venetoclax Acute Myeloid Leukemia with FLT3/ITD Mutation Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07425808 clinical trial report covering Venetoclax, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ACTRN12626000236392 Timolol Cardiovascular Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
ACTRN12626000236392 clinical trial report covering Timolol, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.